Cipla Limited (NSE:CIPLA)
India
· Delayed Price · Currency is INR 1,488.00
-11.40 (-0.76%)
Sep 29, 2025, 3:30 PM IST
Revenue by Product
Fiscal year is April - March.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2005 - 2019 |
| Pharmaceuticals | 264.46B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceuticals Growth | 6.46% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| New Ventures | 13.03B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| New Ventures Growth | 17.24% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Inter Segment | -2.02B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Inter Segment Growth | 12.21% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is April - March.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2005 - 2019 |
| India | 116.15B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| India Growth | 6.82% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States | 78.99B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | 5.30% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of the World | 42.07B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of the World Growth | -15.32% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Africa | 38.26B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| South Africa | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| South Africa Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|